![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Oculocare’s Alleye App Cleared for Monitoring AMD
Oculocare’s Alleye App Cleared for Monitoring AMD
![ClearanceStamp_Gray.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Gray.gif?t=1576043982&width=430)
July 10, 2018
Oculocare’s Alleye, a mobile application was granted 510(k) clearance by the FDA for monitoring eyesight in age-related macular degeneration (AMD).
The app gives patients the ability to regularly test their eyesight and assess the progression of disease without the supervision of a doctor.
It is designed to detect and characterize visual distortion in patients with macular conditions such as AMD and diabetic retinopathy.
Upcoming Events
-
21Oct